ATE382631T1 - Verfahren zur herstellung von virusinaktiviertem humanem gammaglobulin g - Google Patents

Verfahren zur herstellung von virusinaktiviertem humanem gammaglobulin g

Info

Publication number
ATE382631T1
ATE382631T1 AT02380009T AT02380009T ATE382631T1 AT E382631 T1 ATE382631 T1 AT E382631T1 AT 02380009 T AT02380009 T AT 02380009T AT 02380009 T AT02380009 T AT 02380009T AT E382631 T1 ATE382631 T1 AT E382631T1
Authority
AT
Austria
Prior art keywords
inactivated human
producing virus
human gammaglobulin
gammaglobulin
virus
Prior art date
Application number
AT02380009T
Other languages
English (en)
Inventor
Debart Pere Ristol
Gimenez Francisco Rabaneda
Hernandez Teresa Lopez
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Sa filed Critical Grifols Sa
Application granted granted Critical
Publication of ATE382631T1 publication Critical patent/ATE382631T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AT02380009T 2001-01-17 2002-01-11 Verfahren zur herstellung von virusinaktiviertem humanem gammaglobulin g ATE382631T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200100101A ES2184594B1 (es) 2001-01-17 2001-01-17 Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.

Publications (1)

Publication Number Publication Date
ATE382631T1 true ATE382631T1 (de) 2008-01-15

Family

ID=8496419

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02380009T ATE382631T1 (de) 2001-01-17 2002-01-11 Verfahren zur herstellung von virusinaktiviertem humanem gammaglobulin g

Country Status (14)

Country Link
US (1) US6875848B2 (de)
EP (1) EP1225180B1 (de)
JP (1) JP4070468B2 (de)
AR (1) AR032242A1 (de)
AT (1) ATE382631T1 (de)
CZ (1) CZ300413B6 (de)
DE (1) DE60224310T2 (de)
ES (2) ES2184594B1 (de)
HK (1) HK1048324B (de)
HU (1) HU228252B1 (de)
MX (1) MXPA02000639A (de)
PT (1) PT1225180E (de)
SK (1) SK287633B6 (de)
UY (1) UY27126A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
EP3225625A1 (de) 2002-09-11 2017-10-04 Chugai Seiyaku Kabushiki Kaisha Proteinaufreinigungsverfahren
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
BRPI0611901A2 (pt) 2005-06-14 2012-08-28 Amgen, Inc composição, liofilizado, kit, e, processo para preparar uma composição
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
JP2008094722A (ja) * 2006-10-05 2008-04-24 Benesis Corp 免疫グロブリン製剤の製造方法
WO2008100578A2 (en) * 2007-02-14 2008-08-21 Amgen Inc. Method of isolating antibodies by precipitation
TWI489994B (zh) 2008-03-17 2015-07-01 Baxter Healthcare Sa 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
EP3309168A1 (de) 2009-08-06 2018-04-18 F. Hoffmann-La Roche AG Verfahren für verbesserte virenentfernung bei der proteinaufreinigung
HUE028832T2 (en) 2009-09-17 2017-01-30 Baxalta Inc Stable co-formulation of hyaluronidase and immunoglobulin, as well as a process for its preparation
WO2011110598A1 (en) * 2010-03-10 2011-09-15 F. Hoffmann-La Roche Ag Method for purifying immunoglobulin solutions
US20130172536A1 (en) * 2011-08-16 2013-07-04 Shenzhen Weiguang Biological Products Co.,Ltd. Intravenous Cytomegalovirus Human Immune Globulin and Manufacturing Method Thereof
ES2381828B1 (es) 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
CN106103478B (zh) 2014-03-21 2020-04-03 豪夫迈·罗氏有限公司 抗体体内半寿期的体外预测
CN106456813B (zh) 2014-04-15 2020-06-30 勃林格殷格翰国际公司 在制造生物制品期间连续灭活病毒的方法、装置和系统
US10221220B2 (en) * 2014-06-12 2019-03-05 Biosyn Arzneimittel Gmbh Preparation methods for a novel generation of biological safe KLH products used for cancer treatment, for the development of conjugated therapeutic vaccines and as challenging agents
WO2015188869A1 (en) 2014-06-12 2015-12-17 Biosyn Arzneimittel Gmbh Preparation methods for a novel generation of biological safe klh products used for cancer treatment, for the development of conjugated therapeutic vaccines and as challenging agents
JP6521351B2 (ja) 2014-10-14 2019-05-29 テックプロジェクトサービス株式会社 ウィルス不活化およびサンプリング装置
DK3215528T3 (da) 2014-11-06 2019-10-07 Hoffmann La Roche Fc-regionvarianter med modificeret FcRn-binding og anvendelsesfremgangsmåder
PT3135687T (pt) 2015-08-31 2019-05-21 Inst Grifols S A Método para preparação de imunoglobulinas
AU2017214678B2 (en) 2016-02-03 2024-02-01 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material
CN109311965B (zh) 2016-03-11 2023-07-18 勃林格殷格翰国际公司 在制造蛋白质期间连续灭活病毒的方法
KR102372105B1 (ko) * 2016-09-26 2022-03-07 인스티투토 그리폴스, 에스.아. 면역글로블린의 제조방법
PT3528787T (pt) 2016-10-21 2026-03-11 Amgen Inc Formulações farmacêuticas e métodos para produzir as mesmas
US10815270B1 (en) 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164495A (en) * 1976-04-06 1979-08-14 Nordisk Insulinlaboratorium Method of recovering immunoglobulin using a polyol and an alkanoic acid
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
ATE66616T1 (de) * 1982-08-30 1991-09-15 Baxter Int Verfahren zur herstellung von gamma-globulin enthaltenden zusammensetzungen.
US5234685A (en) * 1983-03-16 1993-08-10 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of determining incompatibility-reaction-causing substances in blood products as well as a method of inactivating said incompatibility-reaction-causing substances
JP2547556B2 (ja) * 1987-02-06 1996-10-23 株式会社 ミドリ十字 ｒ−グロブリンの液状製剤
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
DE59309332D1 (de) * 1993-12-27 1999-03-04 Rotkreuzstiftung Zentratrallab Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält
TW541179B (en) * 1997-03-19 2003-07-11 Green Cross Corp Process for preparing immunoglobulin preparation
IL121900A (en) * 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
CN1149100C (zh) * 1997-10-23 2004-05-12 三菱制药株式会社 可室温贮存的免疫球蛋白静脉注射制剂
UA64742C2 (uk) * 1997-12-24 2004-03-15 Альфа Терапевтик Корпорейшн СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ)
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
IL140155A (en) * 1998-06-09 2005-12-18 Statens Seruminstitut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
US6441144B1 (en) * 1999-05-20 2002-08-27 Alpha Therapeutic Corporation Method for repairing dual virally inactivated immune globulin for intravenous administration

Also Published As

Publication number Publication date
EP1225180B1 (de) 2008-01-02
MXPA02000639A (es) 2004-11-01
ES2184594A1 (es) 2003-04-01
JP4070468B2 (ja) 2008-04-02
UY27126A1 (es) 2002-07-31
HK1048324B (en) 2008-02-22
EP1225180A2 (de) 2002-07-24
US6875848B2 (en) 2005-04-05
CZ300413B6 (cs) 2009-05-13
SK582002A3 (en) 2002-10-08
EP1225180A3 (de) 2004-01-28
HUP0200103A2 (hu) 2003-08-28
HK1048324A1 (en) 2003-03-28
JP2003002896A (ja) 2003-01-08
ES2184594B1 (es) 2004-01-01
PT1225180E (pt) 2008-03-18
ES2295308T3 (es) 2008-04-16
HU0200103D0 (en) 2002-03-28
CZ2002131A3 (cs) 2002-09-11
DE60224310D1 (de) 2008-02-14
SK287633B6 (sk) 2011-04-05
US20020151688A1 (en) 2002-10-17
HUP0200103A3 (en) 2004-10-28
HU228252B1 (en) 2013-02-28
DE60224310T2 (de) 2009-01-08
AR032242A1 (es) 2003-10-29

Similar Documents

Publication Publication Date Title
ATE382631T1 (de) Verfahren zur herstellung von virusinaktiviertem humanem gammaglobulin g
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
ATE468309T1 (de) Verfahren zur herstellung von olefinen
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
DE60217489D1 (de) Verfahren zur herstellung von vollfarbenen anzeigetafeln
AT7110U9 (de) Verfahren zur herstellung von amlodipinmaleat
ATE286011T1 (de) Verfahren zur herstellung von 1-octen
ATE374463T1 (de) Verfahren zur herstellung von oxazolidinonen
ATE315099T1 (de) Verfahren zur herstellung von tagatose
ATE296287T1 (de) Verfahren zur herstellung von repaglinide
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
DE50102444D1 (de) Verfahren zur herstellung von isocyanatoorganosilanen
ATE316518T1 (de) Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
DE60210911D1 (de) Verfahren zur Herstellung von dehnungserfassenden Vorrichtungen
DE60103173D1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4-methylpyridin
DE50111560D1 (de) Verfahren zur herstellung von guerbetalkoholen
ATE360610T1 (de) Verfahren zur herstellung von cilastatin
ATE273315T1 (de) Verfahren zur herstellung von n- phosphonomethyliminodiessigsäure
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
DE60230422D1 (de) Verfahren zur herstellung von kohlenwasserstoffen
ATE466836T1 (de) Verfahren zur herstellung von alpha- difluormethylornithin (dfmo)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1225180

Country of ref document: EP